Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8228313 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 9 Pages |
Abstract
CyberKnife-based stereotactic radiotherapy is a feasible approach for isolated recurrent primary, lymph node, or metastatic prostate cancer, offering excellent in-field tumor control and a low toxicity profile. Further investigation is warranted to identify the patients who benefit most from this treatment modality. The optimal combination with androgen deprivation should also be defined.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Barbara Alicja M.D., Ph.D., Giancarlo M.D., Laura M.D., Cristiana M.Sc., Luigi M.Sc., Andrea M.D., Dario M.D., Federica M.D., Carmen M.D., Isa M.D., Roberta M.D., Achille M.Sc., Livia Corinna M.D., Ottavio M.D., Roberto M.D.,